| | |
Circumcision
|
|---|
| |
N
|
No
|
Yes
|
|---|
| | | |
Univariate
|
Multivariable1
|
|---|
| | | |
PR (95% CI)
|
PR (95% CI)
|
|---|
|
Any HPV
|
|
Lifetime number of female partners
| | | |
P = 0.1462
|
|
1-4
|
1099
|
1.00
|
0.97 (0.87-1.08)
|
0.92 (0.81-1.03)
|
|
5-12
|
1183
|
1.00
|
0.98 (0.91-1.07)
|
0.96 (0.88-1.05)
|
|
13+
|
1083
|
1.00
|
1.03 (0.97-1.10)
|
1.03 (0.96-1.10)
|
|
Oncogenic HPV
|
|
Lifetime number of female partners
| | | |
P = 0.2042
|
|
1-4
|
667
|
1.00
|
0.93 (0.73 - 1.19)
|
0.96 (0.73 - 1.26)
|
|
5-12
|
726
|
1.00
|
0.96 (0.82 - 1.12)
|
0.92 (0.77 - 1.09)
|
|
13+
|
697
|
1.00
|
1.06 (0.95 - 1.18)
|
1.06 (0.95 - 1.19)
|
|
Non-Oncogenic HPV
|
|
Lifetime number of female partners
| | | |
P = 0.006
2
|
|
1-4
|
647
|
1.00
|
0.62 (0.45 - 0.83)
|
0.59 (0.42 - 0.83)
|
|
5-12
|
668
|
1.00
|
0.89 (0.74 - 1.07)
|
0.88 (0.72 - 1.08)
|
|
13+
|
542
|
1.00
|
1.03 (0.88 - 1.20)
|
1.03 (0.88 - 1.21)
|
|
Unclassified HPV
|
|
Lifetime number of female partners
| | | |
P = 0.9522
|
|
1-4
|
717
|
1.00
|
1.24 (1.01 – 1.51)
|
1.03 (0.82 – 1.28)3
|
|
5-12
|
527
|
1.00
|
1.25 (0.96 – 1.61)
|
1.15 (0.86 – 1.53)3
|
|
13+
|
330
|
1.00
|
1.19 (0.83 – 1.71)
|
1.10 (0.74 – 1.62)3
|
-
NOTE.
PR, prevalence ratio; CI, confidence interval. Numbers in bold correspond to statistically significant point estimates.
-
1Adjusted for race, marital status, female sexual partners in past 3–6 months and male anal sexual partners in the past 3 months.
-
2Test for interaction between MC and lifetime number of female partners.
-
3Adjusted for race, marital status, and male anal sexual partners in the past 3 months.
